Does the media favor LMAT or TCMD?

In the previous week, LeMaitre Vascular and LeMaitre Vascular both had 3 articles in the media. LeMaitre Vascular's average media sentiment score of 1.04 beat Tactile Systems Technology's score of 0.63 indicating that LeMaitre Vascular is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LeMaitre Vascular 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AXGN or TCMD?

In the previous week, Tactile Systems Technology had 1 more articles in the media than AxoGen. MarketBeat recorded 3 mentions for Tactile Systems Technology and 2 mentions for AxoGen. AxoGen's average media sentiment score of 1.77 beat Tactile Systems Technology's score of 0.63 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TCMD or ESTA?

In the previous week, Tactile Systems Technology had 1 more articles in the media than Establishment Labs. MarketBeat recorded 3 mentions for Tactile Systems Technology and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.49 beat Tactile Systems Technology's score of 0.63 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer NVCR or TCMD?

In the previous week, NovoCure had 5 more articles in the media than Tactile Systems Technology. MarketBeat recorded 8 mentions for NovoCure and 3 mentions for Tactile Systems Technology. NovoCure's average media sentiment score of 0.93 beat Tactile Systems Technology's score of 0.63 indicating that NovoCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NovoCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Tactile Systems Technology (TCMD) Competitors

$24.37 -0.04 (-0.16%)

Closing price 06/3/2026 04:00 PM Eastern

Extended Trading

$24.38 +0.01 (+0.04%)

As of 06/3/2026 05:35 PM Eastern

Compare

TCMD vs. LMAT, AXGN, ESTA, NVCR, and PLSE

Should you buy Tactile Systems Technology stock or one of its competitors? MarketBeat compares Tactile Systems Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tactile Systems Technology include LeMaitre Vascular (LMAT), AxoGen (AXGN), Establishment Labs (ESTA), NovoCure (NVCR), and Pulse Biosciences (PLSE). These companies are all part of the "medical equipment" industry.

How does Tactile Systems Technology compare to LeMaitre Vascular?

LeMaitre Vascular (NASDAQ:LMAT) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, media sentiment and profitability.

LeMaitre Vascular has higher earnings, but lower revenue than Tactile Systems Technology. Tactile Systems Technology is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$249.60M	8.39	$57.73M	$2.71	33.82
Tactile Systems Technology	$329.52M	1.67	$19.09M	$0.88	27.69

LeMaitre Vascular presently has a consensus price target of $112.60, suggesting a potential upside of 22.87%. Tactile Systems Technology has a consensus price target of $38.60, suggesting a potential upside of 58.39%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, analysts plainly believe Tactile Systems Technology is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.75
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

In the previous week, LeMaitre Vascular and LeMaitre Vascular both had 3 articles in the media. LeMaitre Vascular's average media sentiment score of 1.04 beat Tactile Systems Technology's score of 0.63 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

84.6% of LeMaitre Vascular shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 7.4% of LeMaitre Vascular shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

LeMaitre Vascular has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

LeMaitre Vascular has a net margin of 24.35% compared to Tactile Systems Technology's net margin of 5.91%. LeMaitre Vascular's return on equity of 15.36% beat Tactile Systems Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	24.35%	15.36%	9.78%
Tactile Systems Technology	5.91%	9.70%	7.53%

Summary

LeMaitre Vascular beats Tactile Systems Technology on 10 of the 14 factors compared between the two stocks.

How does Tactile Systems Technology compare to AxoGen?

AxoGen (NASDAQ:AXGN) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

AxoGen has a beta of 1.12, indicating that its stock price is 12% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

AxoGen presently has a consensus target price of $46.50, indicating a potential upside of 14.45%. Tactile Systems Technology has a consensus target price of $38.60, indicating a potential upside of 58.39%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, analysts plainly believe Tactile Systems Technology is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

Tactile Systems Technology has a net margin of 5.91% compared to AxoGen's net margin of -13.21%. Tactile Systems Technology's return on equity of 9.70% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-13.21%	-9.63%	-6.26%
Tactile Systems Technology	5.91%	9.70%	7.53%

80.3% of AxoGen shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 2.4% of AxoGen shares are held by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Tactile Systems Technology has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$225.21M	9.59	-$15.70M	-$0.64	N/A
Tactile Systems Technology	$329.52M	1.67	$19.09M	$0.88	27.69

In the previous week, Tactile Systems Technology had 1 more articles in the media than AxoGen. MarketBeat recorded 3 mentions for Tactile Systems Technology and 2 mentions for AxoGen. AxoGen's average media sentiment score of 1.77 beat Tactile Systems Technology's score of 0.63 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Tactile Systems Technology beats AxoGen on 12 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to Establishment Labs?

Tactile Systems Technology (NASDAQ:TCMD) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

Tactile Systems Technology has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.67	$19.09M	$0.88	27.69
Establishment Labs	$211.08M	10.10	-$51.06M	-$1.49	N/A

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by insiders. Comparatively, 10.0% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Tactile Systems Technology has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

Tactile Systems Technology currently has a consensus target price of $38.60, indicating a potential upside of 58.39%. Establishment Labs has a consensus target price of $87.14, indicating a potential upside of 20.35%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, research analysts plainly believe Tactile Systems Technology is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

Tactile Systems Technology has a net margin of 5.91% compared to Establishment Labs' net margin of -19.05%. Tactile Systems Technology's return on equity of 9.70% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
Establishment Labs	-19.05%	-218.77%	-12.31%

In the previous week, Tactile Systems Technology had 1 more articles in the media than Establishment Labs. MarketBeat recorded 3 mentions for Tactile Systems Technology and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.49 beat Tactile Systems Technology's score of 0.63 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Establishment Labs	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Tactile Systems Technology beats Establishment Labs on 12 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to NovoCure?

NovoCure (NASDAQ:NVCR) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

NovoCure presently has a consensus target price of $27.29, suggesting a potential upside of 68.95%. Tactile Systems Technology has a consensus target price of $38.60, suggesting a potential upside of 58.39%. Given NovoCure's higher possible upside, equities analysts clearly believe NovoCure is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NovoCure	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

84.6% of NovoCure shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 5.5% of NovoCure shares are held by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

NovoCure has a beta of 0.93, suggesting that its stock price is 7% less volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

Tactile Systems Technology has lower revenue, but higher earnings than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NovoCure	$655.35M	2.85	-$136.23M	-$1.53	N/A
Tactile Systems Technology	$329.52M	1.67	$19.09M	$0.88	27.69

Tactile Systems Technology has a net margin of 5.91% compared to NovoCure's net margin of -25.66%. Tactile Systems Technology's return on equity of 9.70% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NovoCure	-25.66%	-50.82%	-16.48%
Tactile Systems Technology	5.91%	9.70%	7.53%

In the previous week, NovoCure had 5 more articles in the media than Tactile Systems Technology. MarketBeat recorded 8 mentions for NovoCure and 3 mentions for Tactile Systems Technology. NovoCure's average media sentiment score of 0.93 beat Tactile Systems Technology's score of 0.63 indicating that NovoCure is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NovoCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

NovoCure and Tactile Systems Technology tied by winning 8 of the 16 factors compared between the two stocks.

How does Tactile Systems Technology compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and Tactile Systems Technology (NASDAQ:TCMD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Pulse Biosciences has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market.

77.0% of Pulse Biosciences shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 74.0% of Pulse Biosciences shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Tactile Systems Technology has a net margin of 5.91% compared to Pulse Biosciences' net margin of 0.00%. Tactile Systems Technology's return on equity of 9.70% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	N/A	-86.67%	-73.61%
Tactile Systems Technology	5.91%	9.70%	7.53%

Tactile Systems Technology has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$350K	4,941.59	-$72.78M	-$1.10	N/A
Tactile Systems Technology	$329.52M	1.67	$19.09M	$0.88	27.69

Pulse Biosciences currently has a consensus price target of $30.00, suggesting a potential upside of 20.05%. Tactile Systems Technology has a consensus price target of $38.60, suggesting a potential upside of 58.39%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, analysts plainly believe Tactile Systems Technology is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

In the previous week, Tactile Systems Technology had 2 more articles in the media than Pulse Biosciences. MarketBeat recorded 3 mentions for Tactile Systems Technology and 1 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.93 beat Tactile Systems Technology's score of 0.63 indicating that Pulse Biosciences is being referred to more favorably in the media.

Company	Overall Sentiment
Pulse Biosciences	Positive
Tactile Systems Technology	Positive

Summary

Tactile Systems Technology beats Pulse Biosciences on 13 of the 17 factors compared between the two stocks.

Get Tactile Systems Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TCMD vs. The Competition

Export

Metric	Tactile Systems Technology	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$550.60M	$7.25B	$6.47B	$12.54B
Dividend Yield	N/A	1.23%	2.69%	5.22%
P/E Ratio	27.69	45.06	22.17	24.18
Price / Sales	1.67	74.02	520.79	112.26
Price / Cash	21.19	24.22	41.34	57.13
Price / Book	2.49	7.15	9.84	6.72
Net Income	$19.09M	$159.22M	$3.57B	$337.19M
7 Day Performance	-4.62%	-2.00%	-2.46%	-0.74%
1 Month Performance	N/A	N/A	N/A	-1.69%
1 Year Performance	140.34%	0.95%	26.49%	33.10%

Tactile Systems Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TCMD Tactile Systems Technology	3.9766 of 5 stars	$24.37 -0.2%	$38.60 +58.4%	+137.1%	$550.60M	$329.52M	27.69	1,086
LMAT LeMaitre Vascular	4.8624 of 5 stars	$97.57 -0.2%	$112.60 +15.4%	+10.6%	$2.23B	$249.60M	36.00	490	Positive News Analyst Forecast
AXGN AxoGen	2.9602 of 5 stars	$41.45 +1.3%	$46.50 +12.2%	+257.7%	$2.20B	$225.21M	N/A	450	Positive News
ESTA Establishment Labs	2.8926 of 5 stars	$74.13 +2.7%	$87.14 +17.6%	+97.3%	$2.18B	$211.08M	N/A	1,004	Positive News
NVCR NovoCure	2.8379 of 5 stars	$18.61 +3.6%	$27.29 +46.6%	-5.2%	$2.16B	$655.35M	N/A	1,605	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TCMD) was last updated on 6/4/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tactile Systems Technology (TCMD) Competitors

TCMD vs. LMAT, AXGN, ESTA, NVCR, and PLSE

How does Tactile Systems Technology compare to LeMaitre Vascular?

Summary

How does Tactile Systems Technology compare to AxoGen?

Summary

How does Tactile Systems Technology compare to Establishment Labs?

Summary

How does Tactile Systems Technology compare to NovoCure?

Summary

How does Tactile Systems Technology compare to Pulse Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD vs. The Competition

Tactile Systems Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tactile Systems Technology (TCMD) Competitors

TCMD vs. LMAT, AXGN, ESTA, NVCR, and PLSE

How does Tactile Systems Technology compare to LeMaitre Vascular?

Which has higher valuation & earnings, LMAT or TCMD?

Do analysts rate LMAT or TCMD?

Does the media favor LMAT or TCMD?

Do institutionals and insiders hold more shares of LMAT or TCMD?

Which has more volatility & risk, LMAT or TCMD?

Is LMAT or TCMD more profitable?

Summary

How does Tactile Systems Technology compare to AxoGen?

Which has more volatility & risk, AXGN or TCMD?

Do analysts rate AXGN or TCMD?

Is AXGN or TCMD more profitable?

Do insiders & institutionals believe in AXGN or TCMD?

Which has preferable valuation and earnings, AXGN or TCMD?

Does the media prefer AXGN or TCMD?

Summary

How does Tactile Systems Technology compare to Establishment Labs?

Which has stronger earnings & valuation, TCMD or ESTA?

Do institutionals & insiders hold more shares of TCMD or ESTA?

Which has more risk & volatility, TCMD or ESTA?

Do analysts rate TCMD or ESTA?

Is TCMD or ESTA more profitable?

Does the media refer more to TCMD or ESTA?

Summary

How does Tactile Systems Technology compare to NovoCure?

Do analysts prefer NVCR or TCMD?

Do institutionals and insiders have more ownership in NVCR or TCMD?

Which has more risk & volatility, NVCR or TCMD?

Which has higher valuation and earnings, NVCR or TCMD?

Is NVCR or TCMD more profitable?

Does the media prefer NVCR or TCMD?

Summary

How does Tactile Systems Technology compare to Pulse Biosciences?

Which has more volatility & risk, PLSE or TCMD?

Do institutionals & insiders have more ownership in PLSE or TCMD?

Is PLSE or TCMD more profitable?

Which has preferable earnings & valuation, PLSE or TCMD?

Do analysts prefer PLSE or TCMD?

Does the media favor PLSE or TCMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD vs. The Competition

Tactile Systems Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools